The studies discussed in this paper are concerned with the possible im munopathological relationship between reticuloendothelial system(RES) and neoplasma.
In regard to nonspecific host factors, Pillemer's properdin, that had been considered as one of the factors of natural host resistance, was determined in the sera of cancer patients by both bacteriophage neutralization and zymosan assay methods. The distribution and range of the units of fifty per cent phage neutralization (PhN50) and thoseof zymosan assay in cancer patients are almost the same as in normal subjects in Figs. 1 and 2 . No absolute correlation could be foundbetween the serum properdin levels and theclinical conditions of cancer patients.
Capacities
of humoral immune response in tumor-bearing mice and cancer patients were studied by assaying the serum antibody after active immunization with tetanus toxoid.
Although the primary response to produce anti-tetanus toxin antibody generally falls in mice, the secondary response developed at the same level in tumor-bearing and normal mice when antibody was determined on the 6th day after booster injection of tetanus toxoid. The level of antibody in tumor-bearing mice, however, decreased abruptly on the 12th day, whereas that in normal mice remained unchanged and increased afterward. On the other hand, the primary response to tetanus toxoid developed inhuman, but the level of this response in cancer patients was inferior to that in normal subjects. In the secondary response, however, the cancer group produced an equal or more amounts of antitoxin antibody as normal group. These observations suggest that the cancer patients maintain the capacity of humoral antibody production fairly well even in the late stage, including serum properdin level. The effect of homologous or isologous bone marrow transplantation to prolong the survival time of tumor-bearing animals was presented by us. The possible role of the transplanted bone marrow cells may be to restore the impaired im munological capacity in tumor-bearing animals. In order to elucidate the mech anism ofthe action of bone marrow cells, we are now in attempts if the delayed sensitivity could betransferred to tumor-bearing animals by the repeated injection of bone marrow cells from closely related donors.
